Purpose: To analyse non-psychotropic drug prescription in a prison outpatient clinic in comparison with an urban medical outpatient service.
Methods: Comparative study during 3 weeks at Geneva: prison outpatient service and medical policlinic (MP) of the University Hospital.
Results: The most often prescribed non-psychotropic drugs at the Geneva prison were systemic analgesics (mostly non-steroidal anti-inflammatory drugs (NSAID) and paracetamol), dermatologicals, systemic anti-infectives and drugs for the gastrointestinal system. For most types of non-psychotropic drugs, frequency of prescription as well as the prescribing patterns were similar in the prison ambulatory service and the urban MP. Dermatologicals were prescribed more frequently at the prison than at the MP. Analgetics have been prescribed mainly for osteoarticulary reasons, especially low back pain at the MP, and for traumatism and headache at the prison.
Conclusions: The higher frequency of dermatological prescriptions could be due to prison environmental factors. We do not have arguments for any overprescription of analgesics or other non-psychotropic drugs. The data did not show any prescription or co-prescription of several substances that violated clinical guidelines.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/pds.907 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Enrollment in Medicare is associated with fewer outpatient mental healthcare visits among those with mental health symptoms.
Health Serv Res
December 2024
Department of Economics, Lafayette College, Easton, Pennsylvania, USA.
Objective: To test whether enrolling in traditional Medicare (TM) or Medicare Advantage (MA) at age 65 reduces mental healthcare utilization among individuals with mental health symptoms and low or moderate family incomes.
Study Setting And Design: We employ a fuzzy regression discontinuity design, comparing the likelihood of having an outpatient mental health visit or a psychotropic drug fill among individuals younger than or older than the age 65 Medicare eligibility threshold.
Data Sources And Analytic Sample: We analyze 2014-2021 Medical Expenditure Panel Survey data.
In situ forming PLA and PLGA implants for the parenteral administration of Cannabidiol.
Int J Pharm
August 2024
Department of Pharmaceutics and Food Technology, Faculty of Pharmacy, Complutense University of Madrid, Spain; Institute of Industrial Pharmacy. Faculty of Pharmacy, Complutense University of Madrid, Spain.
Cannabidiol (CBD) is the main non-psychotropic cannabinoid. It has attracted a great deal of interest in the treatment of several diseases such as inflammatory disorders and cancer. Despite its promising clinical interest, its administration is very challenging.
View Article and Find Full Text PDFDiagnostic Transitions from Primary Psychiatric Disorders to Underlying Medical Conditions: A 5-Year Retrospective Survey from a University Hospital Sample.
Alpha Psychiatry
March 2024
Department of Psychiatry, Gazi University, Faculty of Medicine, Ankara, Turkey.
Background: Undiagnosed underlying medical conditions can cause many patients to be followed, for years, by a diagnosis of a primary psychiatric disorder and to receive inappropriate treatment. The aim of this study was to determine the prevalence of patients initially diagnosed with a primary psychiatric disorder but whose symptoms were later attributed to medical conditions. These patients' initial and final diagnoses were also examined.
View Article and Find Full Text PDFObservational evidence linking psychotropic medicines to the dispensing of opioid agents in later life.
Psychogeriatrics
May 2024
Medical School, University of Western Australia, Perth, Australia.
Background: The use of opioid medicines is common in developed countries, particularly among older adults and those with mental health disorders. It is unclear if the association between mental disorders and opioid medicines is causal, or is due to reverse causality or confounding.
Methods: We used a 10% random sample of the Australian Pharmaceutical Benefits Scheme (years 2012-2022) to examine the cross-sectional, case-control and longitudinal association between the dispensing of antidepressants, anxiolytics, hypnotics, antipsychotics and lithium, and opioid medicines.
Systematic analysis of combined oral contraceptive prescription patterns in psychotropic drug users across twelve European countries.
Contraception
April 2024
LVR-University Hospital Essen, Department of Psychiatry and Psychotherapy, Faculty of Medicine, University of Duisburg-Essen, Essen, North Rhine-Westphalia, Germany; Center for Translational Neuro, and Behavioral Sciences, University of Duisburg-Essen, Essen, North Rhine-Westphalia, Germany.
Article Synopsis
- The study aimed to compare how combined oral contraceptives (COCs) are prescribed to women using psychotropic drugs versus those who are not in Europe.
- The analysis included data from over 143,000 women, revealing no significant differences in COC prescriptions between the two groups, with certain progestins being more or less frequently prescribed based on psychotropic drug use.
- The findings suggest that while overall prescribing patterns are similar, there may be specific considerations for certain psychotropic drug users, like those taking St. John's wort, indicating a need for better guidelines for healthcare professionals in these cases.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!